Sign Up Today and Learn More About Hyperscience Stock
Invest in or calculate the value of your shares in Hyperscience or other pre-IPO companies through EquityZen's platform.
About Hyperscience Stock
Founded
2014
Headquarters
New York, NY, US
Total Funding
48.9M
Industries
Software, Data and Analytics, Financial Services
Hyperscience is a technology company that develops AI-based enterprise software designed to automate office work processes. The software uses machine learning to process structured and semi-structured documents, automate data entry, extract key details from invoices, and reconcile compliance-driven data to enable businesses to streamline complex processes automatically and increase productivity. It aims to modernize mission-critical processes and operations for organizations and governments. Krasimir Marinov, Peter Brodsky, and Vladimir Tzankov founded the company in 2014 and headquartered in New York, New York.
Hyperscience Press Mentions
Stay in the know about the latest news on Hyperscience
Hyperscience Enables Transformational AI at Scale with Significant Updates to Core Platform
businesswire • Sep 24, 2024
Hyperscience Appoints JJ Trahan as Executive Vice President of Global Revenue to Drive the Company Through its Next Phase of Growth
businesswire • Aug 26, 2024
Hyperscience Named a Leader in IDC MarketScape: Worldwide Unstructured Intelligent Document Processing (IDP) Software 2024 Vendor Assessment
businesswire • Aug 05, 2024
Hyperscience Unveils New Solution to Unlock GenAI for Mission Critical Applications
businesswire • Aug 05, 2024
Hyperscience Named a Leader in Document Mining and Analytics Platforms Evaluation Report
businesswire • Jun 01, 2024
Investors in Hyperscience
Discover investors in Hyperscience stock and explore their portfolio companies
Hyperscience Management
Leadership team at Hyperscience
Chief Executive Officer
Charlie Newark-French
Chief Technology Officer
Steven Vineyard
Join now and verify your accreditation status to gain access to:
- Hyperscience current valuation
- Hyperscience stock price
- Available deals in Hyperscience and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Hyperscience stock?
Accredited investors can buy pre-IPO stock in companies like Hyperscience through EquityZen funds. These investments are made available by existing Hyperscience shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Hyperscience stock?
Shareholders can sell their Hyperscience stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
